Advertisement

Characteristics of COVID-19-Related Encephalopathy Detailed

0

Of nine patients with CORE, six had movement disorders, seven had frontal syndrome, four had brainstem impairment

Mortality Increased in Association With SARS-CoV-2 U.K. Variant

0

Mortality hazard ratio was 1.64 in association with infection with VOC-202012/1 versus infection with previously circulating variants

Partial Pfizer COVID-19 Vaccination 63 Percent Effective

0

Estimated effectiveness 63 percent for period from more than 14 days after the first dose through seven days after the second dose

Moderna Starts Testing COVID-19 Vaccine in Younger Children

0

Company also testing its vaccine in 3,000 older children, ages 12 to 17 years

Mortality Up With Surgery Within Six Weeks of SARS-CoV-2 Infection

0

When possible, delay of at least seven weeks after SARS-CoV-2 diagnosis should be sought; however, mortality rates higher for those with ongoing symptoms

Societal Costs of Measles Outbreak in Clark County Estimated at $3.4 Million

0

Estimated costs mainly incurred by the public health response to the outbreak, which included 72 cases of measles

COVID-19 Impacting Caregivers of Children With Cancer

0

Changes to medical care, financial disruptions, and emotional distress reported

Statin Use Tied to Better COVID-19 Survival

0

Findings show 53 percent increased survival among patients using statins before hospitalization

COVID-19 Vaccines Given to Americans Top 100 Million

0

As of Monday, more than 37.4 million Americans are now fully vaccinated, 11.3 percent of the total population

AstraZeneca Says Its COVID-19 Vaccine Is Safe, Despite Reports of Deadly Clots

0

The AstraZeneca vaccine, developed with researchers from Oxford University, has been heavily used in Britain